DCT
1:19-cv-01862
Boehringer Ingelheim Pharma Inc v. Aurobindo Pharma Ltd
Log In
Overview
Analysis
General
Parties
Attorneys
Patents
Related Cases
Dockets
General
Filed
10/03/19
Cause of Action
Patent Infringement
Sector
Biotech
Status
Closed
Patent Owner
Operating Company
Source
PACER
Court
D. Delaware
Judge
Period
PO Win Rate
Colm F. Connolly
10/09/19 - 12/12/22
40%
Plaintiff
Party
Name
Ratings
Boehringer-Ingelheim Pharmaceuticals Inc
NPE
L3
B
Boehringer Ingelheim Pharmaceuticals Inc
NPE
L3
B
Boehringer-Ingelheim Corp
NPE
L3
B
Boehringer Ingelheim Corp
NPE
L3
B
Boehringer Ingelheim Intl GmbH
L3
B
Show all (3 more)
Attorney
Name
Ratings
Morris Nichols Arsht & Tunnell LLP
Local
L5
A
Jack B. Blumenfeld
L5
A
Brian P. Egan
L5
B
Megan Dellinger
L4
A
Kirkland & Ellis LLP
L5
A
Leora Ben-Ami
L5
D
Christopher T. Jagoe
L5
E
Jeanna Wacker
L5
E
Mira A. Mulvaney
L4
C
Ashley L. B. Ross
L4
C
Sam Kwon
L3
D
Justin Bova
L3
--
--
Show all (2 more)
Defendant
Party
Name
Ratings
Aurobindo Pharma USA Inc
L4
E
Aurobindo Pharma Ltd
L4
E
Show all (0 more)
Attorney
Name
Ratings
Connolly Bove Lodge & Hutz
L4
B
Arthur G. Connolly, III
L5
E
Withers Bergman
L2
E
Steven A. Moore
L5
A
James E. Nealon
L4
E
Show all (-5 more)